Intrathecal corticosteroids might slow Alzheimer’s disease progression
Joseph Martin Alisky1,21Marshfield Clinic Research Foundation; 2Marshfield Clinic-Thorp Center, Marshfield, Wisconsin, USAAbstract: Anti-inflammatory drugs for treatment and prevention of Alzheimer’s disease have to date proved disappointing, including a large study of low-dose prednis...
Enregistré dans:
Auteur principal: | Joseph Martin Alisky |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2008
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/a7bb9ad46b8e43bebd7a081728de5468 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
An update on the toxicity of Aβ in Alzheimer’s disease
par: Jürgen Götz, et autres
Publié: (2008) -
Update on the use of memantine in Alzheimer’s disease
par: Robert J van Marum
Publié: (2009) -
Ceruloplasmin and iron in Alzheimer’s disease and Parkinson’s disease: a synopsis of recent studies
par: Kristinsson J, et autres
Publié: (2012) -
Brain amyloid β protein and memory disruption in Alzheimer’s disease
par: Weiming Xia
Publié: (2010) -
Present and prospective clinical therapeutic regimens for Alzheimer’s disease
par: Mustafa M Husain, et autres
Publié: (2008)